• Cihat Ünlü

J Turk Ger Gynecol Assoc 2023;24(3):0-0

Dear Colleagues,

It is my great pleasure to introduce the third issue of the “Journal of the Turkish-German Gynecological Association (J Turk Ger Gynecol Assoc)” in the publishing year of 2023. This issue is consisted of seven articles and two reviews that we hope you will read with interest. Also you may have the oppurtunity to read the quiz. Here we share some of our favorite articles that were published in this issue of the journal.

Pelvic organ prolapse affects many women. Laparoscopic sacropexy is the gold standard therapy for apical prolapse. Banerjee and Noé originally introduced laparoscopic pectopexy as a more recent substitute for sacropexy in 2011. You will read an article comparing laparoscopic pectopexy with the standard laparoscopic sacropexy in women with symptomatic apical prolapse.

The most prevalent monogenic hemoglobin disorder in the world is beta-thalassemia. Repeated blood transfusions are used to treat this condition, which was once life-threatening. Hypogonadotropic hypogonadism may develop from the buildup of hemosiderosis in the hypothalamus and pituitary gland, which is also brought on by frequent blood transfusions. You will also read an article which evaluates the alterations in the ovarian reserve of beta-thalassemia patients over a time period of one year.

You will also have the opportunity to read a review discussing the importance of molecular classification for endometrial carcinoma.

Dear Participants,

I am very proud to say that “Congress on the Synthesis of Holistic and Modern Approaches in Gynaecology” was held in İstanbul on 2-3 June 2023 with a great success with more than 500 registered participants. Holistic medical practices in the area of obstetrics and gynecology were discussed at the congress and were enhanced by the insights, advice, and experiences of the entire faculty. I would like to thank all the participants once again for the time and dedication they gave to this event.

Dear Esteemed Readers, Authors and Reviewers,

I am proud to share the official Citescore value of the JTGGA for 2022. According to Scopus data for 2022, JTGGA’s Citescore value has been determined as 2.1. This value demonstrates a noticeable progress compared to our previously announced Citescore value of 1.7 in 2021. Clarivate has also released the 2022 impact factor ratios of journals indexed in SCIE, SSCI, AHCI, and ESCI and updated its yearly Journal Citation Reports (JCR). More than 21,000 journals from 114 countries and 254 research categories are included in the JCR. Impact factor is a measure of the frequency with which the “average article” in a journal was cited in a given year or time period. As a result, the number of citations in the current year is divided by the number of source papers published in that journal in the previous two years to get a journal’s impact factor (JIF). This year, with a JIF of 1.4, the JTGGA is ranked 98/128 in the obstetrics and gynecology category. We sincerely appreciate your support and confidence. We are advancing eagerly to keep expanding and providing value in the field we work in.

Please visit us online at www.jtgga.org and keep in touch with us by following us on Twitter @JtggaOfficial.

We are looking forward to receiving your valuable submissions, thank you in advance for your contributions.


Prof. Cihat Ünlü, M.D.
Editor in Chief of J Turk Ger Gynecol Assoc
President of TGGF